Monopar Therapeutics short interest in 2020

In 2020, Monopar Therapeutics's disclosed short interest ran from 0.10% of shares outstanding on 15 Jul 2020 to 0.37% on 31 Dec 2020, a change of +0.27 percentage points. The year's high was 0.37% on 31 Dec 2020 and its low 0.03% on 31 Jul 2020, averaging 0.24% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.63 days on 30 Nov 2020. Full history: Monopar Therapeutics.

Cite this page

Plain

Short position data for Monopar Therapeutics short interest in 2020: FINRA, compiled by howshorted.com, settlement date 31 Dec 2020. https://howshorted.com/us/company/mnpr/2020/

Wikipedia

<ref>{{cite web |title=Monopar Therapeutics short interest in 2020 short position data |url=https://howshorted.com/us/company/mnpr/2020/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2020-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-monopar-therapeutics-short-interest-in-2-2020-12-31,
  title        = {Monopar Therapeutics short interest in 2020 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/mnpr/2020/}},
  note         = {Data: FINRA, settlement date 31 Dec 2020; accessed 2026-10-13},
  year         = {2020}
}

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2020 in figures

Start of year: 0.10% (15 Jul 2020)
End of year: 0.37% (31 Dec 2020)
Change: +0.27 pp
High: 0.37% (31 Dec 2020)
Low: 0.03% (31 Jul 2020)
Average: 0.24%
Highest days to cover: 2.63 (30 Nov 2020)
SEC filings marked: 8

Every report in 2020

Monopar Therapeutics short interest in 2020
Settlement	Short interest	Days to cover	Filings since previous
15 Jul 2020	0.10%	1.75	10-K filed, results (8-K), 10-Q filed, results (8-K)
31 Jul 2020	0.03%	1.00
13 Nov 2020	0.36%	2.32	10-Q filed, results (8-K), 10-Q filed, results (8-K)
30 Nov 2020	0.28%	2.63
15 Dec 2020	0.32%	1.00
31 Dec 2020	0.37%	1.00

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.